Table 1.
Baseline characteristics
| Characteristic | Value |
|---|---|
| Age, yr, mean (±SD) | 66.1 (±17.4) |
| Male, % | 64.71 |
| Race, % | |
| White | 88.24 |
| Black | 5.88 |
| Asian | 5.88 |
| Past medical history, % | |
| None | 17.60 |
| CAD | 5.90 |
| Stroke | 5.90 |
| COPD | 11.80 |
| DM | 11.80 |
| IVDA | 11.80 |
| Liver disease | 11.80 |
| Hyperlipidemia | 29.41 |
| Alcohol dependence | 11.76 |
| Obesity | 23.53 |
| Admitting diagnosis, % | |
| Pneumonia | 17.65 |
| Sepsis | 29.41 |
| Acute renal failure | 5.88 |
| Aortic aneurysm | 23.53 |
| Other (including pancreatitis, endocarditis, pleural effusion, cardiac arrest) | 41.18 |
| Heart rate, mean (±SD) | 84.4 (±13.9) |
| SBP, mm Hg, mean (±SD) | 112.2 (±19.7) |
| FiO2, %, mean (±SD) | 48.6 (±8.8) |
| PEEP, cm H2O, mean (±SD) | 7.2 (±3.1) |
| Lactate, mmol/L, median (IQR) | 2.9 (1–3.1) |
| Lactate > 2 mmol/L, % | 23.53 |
| Initial thiamine, nmol/L, median (IQR) | 31.9 (16–53) |
| Vasopressor use, % | 47.06 |
| Norepinephrine, n | 5 |
| Phenylephrine, n | 2 |
| Vasopressin, n | 3 |
| Sedation use, % | 82.35 |
| SOFA score, median (IQR) | 5 (4–9) |
| Mortality, n (%) | 6 (35) |
Definition of abbreviations: CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; FiO2 = fraction of inspired oxygen; IQR = interquartile range; IVDA = intravenous drug abuse; PEEP = positive end expiratory pressure; SBP = systolic blood pressure; SOFA = Sequential Organ Failure Assessment.
n = 17.